{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:32:23Z","timestamp":1784327543373,"version":"3.55.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a severe prothrombotic complication of adenoviral vaccines, including the ChAdOx1 nCoV-19 (Vaxzevria) vaccine. The putative mechanism involves formation of pathological anti\u2013platelet factor 4 (PF4) antibodies that activate platelets via the low-affinity immunoglobulin G receptor Fc\u03b3RIIa to drive thrombosis and thrombocytopenia. Functional assays are important for VITT diagnosis, as not all detectable anti-PF4 antibodies are pathogenic, and immunoassays have varying sensitivity. Combination of ligand binding of G protein\u2013coupled receptors (protease-activated receptor-1) and immunoreceptor tyrosine\u2013based activation motif\u2013linked receptors (Fc\u03b3RIIa) synergistically induce procoagulant platelet formation, which supports thrombin generation. Here, we describe a flow cytometry\u2013based procoagulant platelet assay using cell death marker GSAO and P-selectin to diagnose VITT by exposing donor whole blood to patient plasma in the presence of a protease-activated receptor-1 agonist. Consecutive patients triaged for confirmatory functional VITT testing after screening using PF4\/heparin ELISA were evaluated. In a development cohort of 47 patients with suspected VITT, plasma from ELISA-positive patients (n = 23), but not healthy donors (n = 32) or individuals exposed to the ChAdOx1 nCov-19 vaccine without VITT (n = 24), significantly increased the procoagulant platelet response. In a validation cohort of 99 VITT patients identified according to clinicopathologic adjudication, procoagulant flow cytometry identified 93% of VITT cases, including ELISA-negative and serotonin release assay\u2013negative patients. The in\u00a0vitro effect of intravenous immunoglobulin (IVIg) and fondaparinux trended with the clinical response seen in patients. Induction of Fc\u03b3RIIa-dependent procoagulant response by patient plasma, suppressible by heparin and IVIg, is highly indicative of VITT, resulting in a sensitive and specific assay that has been adopted as part of a national diagnostic algorithm to identify vaccinated patients with platelet-activating antibodies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006698","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:23:31Z","timestamp":1654874611000},"page":"3494-3506","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3851-9364","authenticated-orcid":false,"given":"Christine S.M.","family":"Lee","sequence":"first","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"},{"name":"2Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Po Helena","family":"Liang","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"},{"name":"2Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-7213","authenticated-orcid":false,"given":"David E.","family":"Connor","sequence":"additional","affiliation":[{"name":"3Blood, Stem Cell and Cancer Research Laboratory, St. Vincent\u2019s Centre for Applied Medical Research, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia;"},{"name":"4St. Vincent\u2019s Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnibesh","family":"Dey","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-0639","authenticated-orcid":false,"given":"Ibrahim","family":"Tohidi-Esfahani","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Campbell","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Whittaker","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capraro","sequence":"additional","affiliation":[{"name":"2Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[{"name":"5Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia;"},{"name":"6Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia;"},{"name":"7Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea","family":"Donikian","sequence":"additional","affiliation":[{"name":"8Department of Haematology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Kondo","sequence":"additional","affiliation":[{"name":"8Department of Haematology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5712-124X","authenticated-orcid":false,"given":"Sarah M.","family":"Hicks","sequence":"additional","affiliation":[{"name":"9ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9340-8125","authenticated-orcid":false,"given":"Philip Y.-I.","family":"Choi","sequence":"additional","affiliation":[{"name":"9ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9688","authenticated-orcid":false,"given":"Elizabeth E.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"9ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Joanne","family":"Clarke","sequence":"additional","affiliation":[{"name":"2Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia;"},{"name":"10Australian Red Cross Lifeblood, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[{"name":"11Clinical Haematology Department, The Alfred Hospital, Melbourne, VIC, Australia;"},{"name":"12Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda H.","family":"Passam","sequence":"additional","affiliation":[{"name":"13Central Clinical School, University of Sydney, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Andrew","family":"Brighton","sequence":"additional","affiliation":[{"name":"8Department of Haematology, New South Wales Health Pathology, Prince of Wales Hospital, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7470","authenticated-orcid":false,"given":"Vivien M.","family":"Chen","sequence":"additional","affiliation":[{"name":"1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia;"},{"name":"2Department of Haematology, Concord Repatriation General Hospital and NSW Health Pathology, Sydney, NSW, Australia;"},{"name":"14Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"issue":"22","key":"2022061015222997500_B1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med."},{"issue":"22","key":"2022061015222997500_B2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med."},{"issue":"23","key":"2022061015222997500_B3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N Engl J Med."},{"key":"2022061015222997500_B4","author":"ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine-Induced Immune Thrombotic Thrombocytopenia (Updated 20 April, 2021): International Society on Thrombosis and Haemostasis","year":"2021"},{"issue":"6","key":"2022061015222997500_B5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5694\/mja2.51229","article-title":"Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia","volume":"215","author":"Chen","year":"2021","journal-title":"Med J Aust."},{"issue":"7873","key":"2022061015222997500_B6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature."},{"issue":"14","key":"2022061015222997500_B7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.2021012938","article-title":"Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood."},{"issue":"4","key":"2022061015222997500_B8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood.2021012217","article-title":"Frequency of positive anti-PF4\/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2","volume":"138","author":"Thiele","year":"2021","journal-title":"Blood."},{"issue":"6","key":"2022061015222997500_B9","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"20","key":"2022061015222997500_B10","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood-2017-05-787259","article-title":"Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis","volume":"130","author":"Agbani","year":"2017","journal-title":"Blood."},{"key":"2022061015222997500_B11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ijlh.13197","article-title":"Procoagulant platelets: laboratory detection and clinical significance","volume":"42","author":"Tohidi-Esfahani","year":"2020","journal-title":"Int J Lab Hematol."},{"issue":"8","key":"2022061015222997500_B12","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","volume":"106","author":"Althaus","year":"2021","journal-title":"Haematologica."},{"issue":"6","key":"2022061015222997500_B13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mlc.2001.120049","article-title":"Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins","volume":"138","author":"Batar","year":"2001","journal-title":"J Lab Clin Med."},{"issue":"7","key":"2022061015222997500_B14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09537104.2020.1859103","article-title":"Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity","volume":"32","author":"Fern\u00e1ndez","year":"2021","journal-title":"Platelets."},{"issue":"6","key":"2022061015222997500_B15","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/jth.14008","article-title":"Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response","volume":"16","author":"Pasalic","year":"2018","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022061015222997500_B16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0034-1544002","article-title":"Procoagulant platelets and the pathways leading to cell death","volume":"41","author":"Hua","year":"2015","journal-title":"Semin Thromb Hemost."},{"key":"2022061015222997500_B17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4939-9187-7_20","article-title":"Flow cytometry assessment of procoagulant platelets using a dithiol-reactive probe","volume":"1967","author":"Tan","year":"2019","journal-title":"Methods Mol Biol."},{"key":"2022061015222997500_B18","volume-title":"Updated August 19, 2021.","author":"THANZ Advisory Statement for Haematologists on Suspected Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT)","year":"2021"},{"issue":"12","key":"2022061015222997500_B19","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1111\/jth.13516","article-title":"Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH","volume":"14","author":"Morel-Kopp","year":"2016","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022061015222997500_B20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/jth.15650","article-title":"Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia","volume":"20","author":"Lee","year":"2022","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022061015222997500_B21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(89)90086-8","article-title":"Improved method for purification of human platelet factor 4 by affinity and ion-exchange chromatography","volume":"54","author":"Medici","year":"1989","journal-title":"Thromb Res."},{"issue":"1","key":"2022061015222997500_B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood."},{"issue":"12","key":"2022061015222997500_B23","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1111\/j.1538-7836.2011.04487.x","article-title":"Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series","volume":"9","author":"Warkentin","year":"2011","journal-title":"J Thromb Haemost."},{"issue":"6510","key":"2022061015222997500_B24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science."},{"issue":"8","key":"2022061015222997500_B25","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med."},{"issue":"4","key":"2022061015222997500_B26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJMc2106383","article-title":"PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia","volume":"385","author":"Vayne","year":"2021","journal-title":"N Engl J Med."},{"issue":"18","key":"2022061015222997500_B27","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med."},{"issue":"26","key":"2022061015222997500_B28","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood.2021012064","article-title":"A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination","volume":"137","author":"Handtke","year":"2021","journal-title":"Blood."},{"issue":"9","key":"2022061015222997500_B29","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/jth.15423","article-title":"Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: results from a UK National External Quality Assessment Scheme exercise April 2021","volume":"19","author":"Reilly-Stitt","year":"2021","journal-title":"J Thromb Haemost."},{"key":"2022061015222997500_B30","article-title":"The structure of ChAdOx1\/AZD-1222 reveals interactions with CAR and PF4 with implications for vaccine-induced immune thrombotic thrombocytopenia.","author":"Baker","journal-title":"bioRxiv"},{"issue":"22","key":"2022061015222997500_B31","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.2021013231","article-title":"Insights in ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"138","author":"Greinacher","year":"2021","journal-title":"Blood."},{"issue":"19","key":"2022061015222997500_B32","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMc2112760","article-title":"Decline in pathogenic antibodies over time in VITT","volume":"385","author":"Sch\u00f6nborn","year":"2021","journal-title":"N Engl J Med."},{"issue":"3","key":"2022061015222997500_B33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie."},{"issue":"3","key":"2022061015222997500_B34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09537104.2017.1378808","article-title":"Development of a high-yield expression and purification system for platelet factor 4","volume":"29","author":"Huynh","year":"2018","journal-title":"Platelets."},{"issue":"5","key":"2022061015222997500_B35","doi-asserted-by":"crossref","first-page":"e0232661","DOI":"10.1371\/journal.pone.0232661","article-title":"High-yield production of recombinant platelet factor 4 by harnessing and honing the gram-negative bacterial secretory apparatus","volume":"15","author":"Ataei","year":"2020","journal-title":"PLoS One."},{"issue":"3","key":"2022061015222997500_B36","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jth.14385","article-title":"Human low-affinity IgG receptor Fc\u03b3RIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus","volume":"17","author":"Clancy","year":"2019","journal-title":"J Thromb Haemost."},{"issue":"15","key":"2022061015222997500_B37","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1182\/blood-2014-09-594515","article-title":"Increased risk of thrombosis in Fc\u03b3RIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2","volume":"125","author":"Rollin","year":"2015","journal-title":"Blood."},{"issue":"7","key":"2022061015222997500_B38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0040-1712957","article-title":"Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the literature","volume":"120","author":"Gruel","year":"2020","journal-title":"Thromb Haemost."},{"issue":"5","key":"2022061015222997500_B39","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1182\/blood-2002-07-2149","article-title":"An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN","volume":"101","author":"Dupont","year":"2003","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3494\/1901289\/advancesadv2021006698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/11\/3494\/1901289\/advancesadv2021006698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:03:03Z","timestamp":1675807383000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/11\/3494\/484510\/A-novel-flow-cytometry-procoagulant-assay-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,6,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006698","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}